News Picture Generic

Chemspeed celebrates its 10th anniversary with Bayer HealthCare

January 7, 2012

Chemspeed recently celebrated 10 full operating years with Bayer HealthCare Pharmaceuticals (Bayer) in Berlin, Germany it runs five Chemspeed instruments in its laboratories. Building on the instrument reliability, Bayer is now moving to the next generation of Chemspeed’s equipment. Chemspeed was contacted by Bayer HealthCare Pharmaceuticals eleven years ago. The idea was to support the medicinal chemistry projects at Bayer using automated parallel synthesis which needed to be as flexible as possible. Chemspeed had developed the Chemspeed Synthesizer ASW2000 which was the first and only equipment which met Bayer’s needs at that time. Bayer HealthCare Pharmaceuticals bought the Synthesizer ASW2000 and later on, the Accelerator Synthesizer. Today, Bayer has five Synthesizers that are used on a regular basis. Each Synthesizer is programmed and configured identically, allowing easy exchange of program files or system accessories like reactors. The Chemspeed Synthesizer is the only fully integrated and automated workstation in the world for reaction preparation, synthesis (ambient pressure and pressure up to 100bar), work up, purification, analysis, output to storage vials / plates, incl. chemistry under inert gas (e.g. handling BuLi) and low-temperature (down to -70°C). Chemspeed’s instruments are still relevant today as the project orientation became even stronger recent the years. At Bayer, the project share for libraries nowadays is approaching 90%. Dr. Koppitz, Senior Scientist at Bayer HealthCare Pharmaceuticals said: “We like the platform approach which can be easily adapted to the different requirements at Bayer.

About Bayer HealthCare Pharmaceuticals Bayer HealthCare Pharmaceuticals' goal is to discover products that will improve human health worldwide by diagnosing, preventing and treating diseases. As a specialty pharmaceutical company, they focus their efforts where they can have the most impact. For more than 100 years, Bayer has been dedicated to developing, manufacturing and marketing pharmaceuticals. Built on the company's long history of providing medicines that healthcare providers and patients can trust, Bayer is one of the most recognized brands in healthcare. Additional information

Other Recent News

Discover more news articles you might be interested in

Read more about Toward fully autonomous closed-loop molecular discovery – A case study on JAK targets
News Picture 1 1 V2
Featured
Feb
3

Toward fully autonomous closed-loop molecular discovery – A case study on JAK targets

Bridging AI and self-driving laboratories, we introduce the first fully-automated, closed-loop molecular discovery cycle, exemplified by the identification of novel JAK inhibitors. With minimal human intervention, we combined AI-driven molecular design and retrosynthesis with IBM’s synthesis automation system RoboRXN and Arctoris’ Ulysses platform for automated in-vitro screening.

Read more about Altana tests coatings for the industry in a unique high-throughput facility worldwide / Altana testet Lacke fuer die Industrie in weltweit einmaliger Hochdurchsatzanlage
News Picture 1 1 V2
Featured
Jan
30

Altana tests coatings for the industry in a unique high-throughput facility worldwide / Altana testet Lacke fuer die Industrie in weltweit einmaliger Hochdurchsatzanlage

VDI news / nachrichten

Up to 220 paint samples per day go through a fully automated screening in a unique testing facility at Byk in Wesel. / Bis zu 220 Lackproben pro Tag durchlaufen ein vollautomatisches Screening in einer weltweit einmaligen Pruefanlage bei Byk in Wesel.

Read more about Asymmetric hydrogenation of olefins with transition metal-based catalysts: practical insights from screening to production of APIs
News Picture 1 1 V2
Featured
Jan
20

Asymmetric hydrogenation of olefins with transition metal-based catalysts: practical insights from screening to production of APIs

Selective hydrogenation plays a critical role in modern synthetic chemistry, particularly in the pharmaceutical industry, where the production of chiral molecules with high enantiomeric purity is essential for the efficacy and safety of active pharmaceutical ingredients (APIs). 

© Chemspeed Technologies 2026